Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Wayfair Inc (W) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Wayfair Inc — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Wayfair Inc trades at $104.22 (market cap $14.79B). The key difference: Wayfair Inc is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is more actively traded (779,107 versus 1,870,669). Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Wayfair Inc for 8 Days on average.
| KYMR | W | |
|---|---|---|
Market Cap | $8.87B | $14.79B |
Volume | 779,107 | 1,870,669 |
Sector | Health | Consumer Cyclical |
52-Week High | $127.31 | $119.05 |
52-Week Low | $55.80 | $57.40 |
Typical Hold Time | 0 Days | 8 Days |
Enterprise Value | $8.26B | $17.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wayfair (W) trades at $107.99, up 1.74% on the day, with a bullish technical signal from moving averages. The company reported revenue of $12.46B in 2025 but a net loss of $313M, with a negative net income margin of -2.49%. Analyst consensus is positive with a $114.13 price target, and recent news highlights brand expansion and upcoming Q3 2026 earnings.
The outlook for Wayfair hinges on improving profitability amid competitive pressures. While revenue growth is steady, persistent losses and high debt-to-asset ratio of 95.11% pose risks. The stock offers upside to the consensus target but requires monitoring of cost management and consumer spending trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Wayfair Inc
Wayfair is a global leader in home goods, operating a massive digital marketplace that connects millions of consumers with thousands of suppliers. It utilizes an asset-light, inventory-light model combined with a proprietary logistics network (CastleGate) and an accelerating brick-and-mortar presence to deliver an end-to-end shopping experience for everything from decor to full home renovations.
Read more on W →
